Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-30 @ 4:44 AM
Study NCT ID:
NCT07464951
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-11
First Post:
2026-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
Sponsor:
Stephan Grupp MD PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-04
First Submit QC Date:
None
Study First Post Date:
2026-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-07
Last Update Post Date:
2026-03-11
Last Update Post Date Type:
ACTUAL